Back to Journals » OncoTargets and Therapy » Volume 18 » default
OncoTargets and Therapy
- View all (6729)
- Volume 19, 2026 (44)
- Volume 18, 2025 (105)
- Volume 17, 2024 (142)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 18, 2025
- default (105)
- Advances in Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatment (5)
MicroRNA-29a Plays a Suppressive Role in Non-Small Cell Lung Cancer Cells via Targeting LASP1 [Retraction]
Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S
OncoTargets and Therapy 2025, 18:1363-1364
Published Date: 19 December 2025
Clinical Significance of MYBL2 Expression in Hepatocellular Carcinoma: Impact on Overall Survival
Chen CC, Wei CT, Hsuan CF, Yu TH, Hung WC, Wu CC, Lee TL, Tang WH, Chung FM, Lee YJ, Hsu CC
OncoTargets and Therapy 2025, 18:1353-1362
Published Date: 16 December 2025
Brain Metastatic Tumor Flare After Sunvozertinib Dose Reduction in a Patient with Surgical Resected EGFR ex20ins NSCLC
Yan W, Yang N, Wang G, Bao W, Liang Q, Lv T, Ye M, Zhang F, Yin J
OncoTargets and Therapy 2025, 18:1347-1352
Published Date: 8 December 2025
Prognostic Impact of Pre-Treatment CRP/Albumin Ratio in Patients with Advanced-Stage Epithelial Ovarian Cancer
Atalah F, Karakök A, Acarbay A, Beşiroğlu M, Gümüş M
OncoTargets and Therapy 2025, 18:1337-1346
Published Date: 5 December 2025
Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer
Huang J, Wang J, Zheng D, Chen J
OncoTargets and Therapy 2025, 18:1329-1336
Published Date: 4 December 2025
Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma
Qiu M, Xu L
OncoTargets and Therapy 2025, 18:1313-1327
Published Date: 27 November 2025
SNRPE is Associated with ERK/mTOR Signaling Activation and Reduced Autophagy to Promote Lung Adenocarcinoma Cell Proliferation
Yang J, Dai W, Ren B, Chen H, Dang X, Jiang L
OncoTargets and Therapy 2025, 18:1299-1312
Published Date: 15 November 2025
Icariin Inhibits Lung Adenocarcinoma Progression Through TP53-Mediated Ferroptosis
Jin Q, OuYang L, Li J, Yang X, Guo L
OncoTargets and Therapy 2025, 18:1281-1298
Published Date: 15 November 2025
Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions
Al-Shamsi HO, Rasul Snr K, Shablak A, ALnajjar A, Shabaan AMA, Al Sindi M, Nasr M, AlJabban A, Rafii S
OncoTargets and Therapy 2025, 18:1265-1279
Published Date: 15 November 2025
Redefining Therapeutic Boundaries: PD-1 Blockade Facilitates Surgical Cure in EGFR-TKI Refractory EGFR-Mutant NSCLC with Pleural Metastases
Niu YL, Teng XB, Han MF, Ma J
OncoTargets and Therapy 2025, 18:1259-1264
Published Date: 11 November 2025
Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma [Retraction]
Lei D, Hu G, Chen Y, Hao T, Gao Y, Luo F
OncoTargets and Therapy 2025, 18:1257-1258
Published Date: 7 November 2025
Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study
Wang Y, Xie Q
OncoTargets and Therapy 2025, 18:1243-1256
Published Date: 7 November 2025
Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746
Guan M, Shi Q, Ye W, Gu K
OncoTargets and Therapy 2025, 18:1227-1241
Published Date: 7 November 2025
Decoding the Prognosis-Related S100A9high Monocyte in Glioblastoma Using Single-Cell and Spatial Transcriptome Sequencing
Li X, Qin Y, Gao P, Wang H, Liu Y, Ren L, Wu D, Heng X
OncoTargets and Therapy 2025, 18:1211-1226
Published Date: 5 November 2025
miR-424-3p Contributes to the Malignant Progression and Chemoresistance of Gastric Cancer [Retraction]
Li Y, Liu H, Cui Y, Chen H, Cui X, Shao J, Su F, He X
OncoTargets and Therapy 2025, 18:1209-1210
Published Date: 1 November 2025
Real-World Experience of Niraparib as Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian Cancer: A Single-Center Retrospective Study
Liu W, Zhang L, Wu H, Chen Y, Ma Y, Bao L, Fu X, Wang K
OncoTargets and Therapy 2025, 18:1201-1208
Published Date: 29 October 2025
Metastatic Laryngeal Minor Salivary Gland Carcinoma to the Liver: Successful Treatment with Anti-EGFR-Based Combination Therapy - A Case Report and Literature Review
Guo Z, Li Q, Hong D, Wei Y, Wang Z
OncoTargets and Therapy 2025, 18:1195-1200
Published Date: 27 October 2025
Personalized Treatment for Invasive Ductal Breast Carcinoma with Lung and Liver Metastases Based on Patient-Derived Organoids: A Case Report
Zheng M, Yao L, Jing N, Wang Y, Wang X, Yang J
OncoTargets and Therapy 2025, 18:1189-1194
Published Date: 25 October 2025
Evaluating the Prognostic Value of a Pan-Cancer Circulating Tumor DNA Next-Generation Sequencing Panel in Advanced Cancer Patients
Lee J, Cho JH, Lee S, Kim HS, Han SJ, Jung Y, Byun JH, Kim M
OncoTargets and Therapy 2025, 18:1179-1188
Published Date: 25 October 2025
L-Sarcolysine Reduced the Mobility of Human Glioblastoma Cells, with Potential Involvement of Vimentin
Azadbeigi P, Moosavinejad N, Rassouli FB
OncoTargets and Therapy 2025, 18:1169-1178
Published Date: 18 October 2025
Advances in the Use of Immune Checkpoint Inhibitors for Colorectal Cancer Treatment
Li J, Fu T, Wen Z, Liang J, Qiu Y, Li K, Yang J, Tong Y, Cai H
OncoTargets and Therapy 2025, 18:1159-1168
Published Date: 15 October 2025
Analysis and Exploration of the Relationship Between the Status of Serum Tumor Markers and Clinicopathological Features and Curative Effects in Gastric Cancer and Gastroesophageal Junction Tumor
Xiao Y, Xing Z, Li Z, Jia G, Cheng P, Chen Y, Sun L, Lu C
OncoTargets and Therapy 2025, 18:1149-1157
Published Date: 11 October 2025
Precision Nanomedicine for Cancer: Innovations, Strategies, and Translational Challenges
Wen F, Wang L, Li X, Zhao J, Xu T, Zhu J, Ma L, Wang X
OncoTargets and Therapy 2025, 18:1125-1148
Published Date: 10 October 2025
Development of a Prognostic m6A-Related lncRNA Signature and Functional Validation of FAM83A-AS1 in Lung Adenocarcinoma
Zhang G, Liu C, Wang Y
OncoTargets and Therapy 2025, 18:1107-1123
Published Date: 30 September 2025
Ebp1 p48 Promotes Oncogenic Properties in Non-Small Cell Lung Cancer Through PI3K/Akt Signaling Pathways
Ma L, Wang S, Zhang J, Xin M, Xu D, Liu L, Li X
OncoTargets and Therapy 2025, 18:1093-1105
Published Date: 22 September 2025
Influence of Human Papillomavirus E6 Gene Mutation on Brain-Derived Neurotrophic Factor Regulation and Cell Proliferation in Cervical Neoplasia: Insights Into Molecular Mechanisms
Wei L, Yu Q, Chen SN
OncoTargets and Therapy 2025, 18:1083-1091
Published Date: 22 September 2025
Vitamin C Selectively Inhibits Kidney Renal Clear Cell Carcinoma Cell Growth by Suppressing the HIF-1 Pathway
Wang C, Zhou Y, Liang Y, Pan J, Qiao J, Chen L, Liu S, Chen J, Wang J, Sun X, Ma J, Cai M
OncoTargets and Therapy 2025, 18:1069-1081
Published Date: 20 September 2025
Could Silent Inflammation Originating in Jawbone Cavitations Play a Role in Activating the CCL5/CCR5 Axis in Female Breast Cancer? A Diagnostic and Therapeutic Gap in Osteoimmunological Interactions
Vasconcelos e Cruz J, Perko S, Doebis C, Notter F, Schick F, Lechner J
OncoTargets and Therapy 2025, 18:1053-1068
Published Date: 19 September 2025
Serum Response Factor Expression, Microvascular Density, and Postoperative Recurrence in Glioblastoma
Tan B, He S, Chen T, Song P, Huang Y, Yin X
OncoTargets and Therapy 2025, 18:1043-1052
Published Date: 19 September 2025
Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study
Li C, Cai P, Zeng H, Li J, Hu H, Zhang J, Wu Z, Qin G, Deng Y
OncoTargets and Therapy 2025, 18:1027-1042
Published Date: 18 September 2025
Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?
Zhao Q, Luo X, Xing H, Jiang C, Ma J, Tang L
OncoTargets and Therapy 2025, 18:1013-1025
Published Date: 12 September 2025
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets
Solmonese L, Lofiego MF, Fazio C, Marzani F, Piazzini F, Bello E, Celesti F, Giacobini G, Wang X, Maio M, Coral S, Di Giacomo AM, Covre A
OncoTargets and Therapy 2025, 18:995-1012
Published Date: 10 September 2025
The Dual Role of RBBP7 in Esophageal Squamous Cell Carcinoma: Cell Context-Dependent Impacts on Proliferation and Radiosensitivity
Li Y, Lu S, Yao H, Zhu G, Liu H, Ma Z, Tang H
OncoTargets and Therapy 2025, 18:979-994
Published Date: 4 September 2025
Mi-Lnc70 Regulates the Progression of Murine Pancreatic β-Cell Line and Affects the Synthesis of Insulin and Glucagon
Yuan W, Sun D, Wang J, Yue Y, Li X
OncoTargets and Therapy 2025, 18:967-978
Published Date: 3 September 2025
Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer
Liu J, Cai Y, Liu J, Chen D, Wu X
OncoTargets and Therapy 2025, 18:953-966
Published Date: 29 August 2025
CD93: A Promising NETs-Related Biomarker for Diagnosis and Therapy in Actinic Keratosis
Ke G, Yuan T, Wu C, Gao M
OncoTargets and Therapy 2025, 18:935-951
Published Date: 27 August 2025
The Role of CELMoD Agents in Multiple Myeloma
van de Donk NW, Bahlis NJ, Pawlyn C, Gay F, Mateos MV, Weisel K, Lonial S, Richardson PG
OncoTargets and Therapy 2025, 18:921-933
Published Date: 27 August 2025
Crosstalk Between Immunity and Oncogenes Within the Tumor Microenvironment of HPV-Associated Cervical Squamous Cell Carcinoma
Alahmadi RM, Al Rawi HZ, Awadalla M, Saeed B, Abdelazeem B, Alshanbari HM, Alosaimi B
OncoTargets and Therapy 2025, 18:899-920
Published Date: 15 August 2025
Migrasome-Related Prognostic Genes in Gastric Cancer: A Transcriptomic and Immunotherapeutic Analysis
Qiu W, Zhang K, Hu W, Liu D
OncoTargets and Therapy 2025, 18:873-897
Published Date: 13 August 2025
Innovative Biomarkers for Diagnosing Malignant Ascites in Liver Cancer
Zhang Y, Wu J, Cui H, Zhang X, He L, Gu K, Xu A
OncoTargets and Therapy 2025, 18:865-872
Published Date: 11 August 2025
Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling [Retraction]
Zhou J, Di M, Han H
OncoTargets and Therapy 2025, 18:863-864
Published Date: 7 August 2025
The Expression and Clinical Significance of ALDOA in Breast Cancer
Dai Y, Yang Y, Li X, Shi G, Ni T, Zhu Q, He Q, Hu A, Jiang H, Liu J, Lu T, Sun J, Yu E, Sun L
OncoTargets and Therapy 2025, 18:845-862
Published Date: 4 August 2025
Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors – A Systematic Review and Meta-Analysis
Pichel RC, Benini L, Romelli M, Gandini S, Gervaso L, Valente M, De Sousa MJ, Araújo A, Araújo A, Di Giacomo AM, Fazio N
OncoTargets and Therapy 2025, 18:833-843
Published Date: 31 July 2025
Advances in ORMDL Research in Malignant Tumors: A Review
Wang H, Yi Z, Yan S, Wang Y, Zhang W, Guo R, Li Y, Wang R, Li H, Li X, Song J
OncoTargets and Therapy 2025, 18:821-832
Published Date: 28 July 2025
Multiclonal Profiling of FLT3-ITD in AML Using MinION Sequencing: A Tailored Clustering Approach to Enhance Subclonal Detection
Martínez-Serra J, Alonso-Carballo A, Horrillo Á, Gómez P, Vögler O, Gutiérrez A, Sampol A
OncoTargets and Therapy 2025, 18:811-820
Published Date: 19 July 2025
A Rare Histologic Transformation from EGFR-Positive Lung Adenocarcinoma to EGFR-Negative Squamous Cell Carcinoma After EGFR-TKIs Resistance: A Case Report
Qiu M, Guo P, Lin J, Wang S, Wang W, Yang J, Huang Z, Cao Y
OncoTargets and Therapy 2025, 18:803-809
Published Date: 18 July 2025
Biomarker and Prognostic Value of Super-ARMS Detection for EGFR Mutation in Advanced NSCLC
Liu H, Li H, Xiao L, Guo Y, Lin G
OncoTargets and Therapy 2025, 18:789-801
Published Date: 8 July 2025
The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC
Chen C, Chen L, Zheng W, Dai Y
OncoTargets and Therapy 2025, 18:779-788
Published Date: 7 July 2025
Multi‑cohort Validation Based on Disulfidptosis-Related lncRNAs for Predicting Prognosis and Immunotherapy Response of Esophageal Squamous Cell Carcinoma
Yi Z, Li X, Li Y, Ji Y, Zhao J, Xu H, Zhou L, Song J
OncoTargets and Therapy 2025, 18:763-778
Published Date: 25 June 2025
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy
Chuang TI, Hsu KH, Lee PH, Tseng JS, Hsu YW, Liao CH, Huang YH, Yang TY
OncoTargets and Therapy 2025, 18:751-761
Published Date: 25 June 2025
Lidocaine as a Potential Therapeutic Agent in Colorectal Cancer: A Study of Gene Expression and Prognosis
Li W, Gao W, Lu C, Ji M, Yin Y, Zhang H, Liu C, Yu C
OncoTargets and Therapy 2025, 18:737-749
Published Date: 18 June 2025
Traditional Chinese Medicine Xiaoai Jiedu Recipe Suppresses the Development of Hepatocellular Carcinoma via Regulating the microRNA-29a/Signal Transducer and Activator of Transcription 3 Axis [Retraction]
Shi Y, Kong W, Lu Y, Zheng Y
OncoTargets and Therapy 2025, 18:735-736
Published Date: 11 June 2025
Crosstalk Between EGFR and Integrin Affects Invasion and Proliferation of Gastric Cancer Cell Line, SGC7901 [Retraction]
Dan L, Jian D, Na L, Xiaozhong W
OncoTargets and Therapy 2025, 18:733-734
Published Date: 10 June 2025
IGFBP1 is One of 10 Metabolic Factors Predicting Recurrence Free Survival in Gastric Cancer and Promotes Cancer Progression via ZFX-IGFBP1 Axis
Liu H, Huang Y, Fu G, Lei B, Liu K
OncoTargets and Therapy 2025, 18:717-732
Published Date: 5 June 2025
Studying Immunogenic Cell Death in Human Colorectal Cancer Organoids
Lisandrelli R, Winkler M, Trajanoski Z, Lamberti G
OncoTargets and Therapy 2025, 18:705-715
Published Date: 6 June 2025
Lowering the Selinexor Dose within the Pomalidomide and Dexamethasone Combination Regimen Elicits Fewer Side Effects While Comparable Efficacy Against Relapsed/Refractory Multiple Myeloma
Peng L, Shan T, Zhou X, Feng Z, Qiang W, Lu J, He H, Du J
OncoTargets and Therapy 2025, 18:695-703
Published Date: 6 June 2025
MAM Domain Containing 2 (MAMDC2) Affects Invasion and Metastasis of Human Gastric Cancer
Shen J, Gao G, Liu S
OncoTargets and Therapy 2025, 18:679-693
Published Date: 26 May 2025
Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes
Brighi N, Schepisi G, Conteduca V, Scarpi E, Caroli P, Matteucci F, Lolli C
OncoTargets and Therapy 2025, 18:667-677
Published Date: 23 May 2025
CXCL11: A Novel Biomarker in Colorectal Cancer as Metastasis Predictor
Wibowo R, Sribudiani Y, Lukman K, Rudiman R, Ruchimat T, Sulthana BAAS, Purnama A, Wijaya A, Primastari E, Nugraha P
OncoTargets and Therapy 2025, 18:657-665
Published Date: 14 May 2025
Risk of Residual Axillary Lymph Node Macrometastasis in Early Breast Cancer PATIENTS with One Positive Macrometastasis Sentinel Lymph Node
Liu DY, Zhu Y, Xie Q, Deng J, Chen BL
OncoTargets and Therapy 2025, 18:647-656
Published Date: 12 May 2025
lncSLERT Promotes Liver Metastasis in Colorectal Cancer by Down-Regulating HUNK Expression via RBM15-Mediated m6A Modification
Wang L, Zhao L, Liu J, Cheng P, Han M, Zheng Z
OncoTargets and Therapy 2025, 18:631-646
Published Date: 9 May 2025
Targeting the Inactive Conformation of the Epidermal Growth Factor Receptor Identifies EG31: A Novel Small Molecule Inhibitor Effective Against Normal and 5-Fluorouracil-Resistant Triple Negative Breast Cancer Cells
Otifi HM
OncoTargets and Therapy 2025, 18:617-629
Published Date: 7 May 2025
Measles Virus-Based Genetic Modifications: Progress in Hematological Malignancy Treatment
Lan S, Zhao Z, He Z
OncoTargets and Therapy 2025, 18:605-615
Published Date: 25 April 2025
Efficacy and Safety of Combined PD-1 Inhibitor with Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis [Corrigendum]
Chen K, Huang X, Chen J, Zhang S
OncoTargets and Therapy 2025, 18:603-604
Published Date: 23 April 2025
A Pyroptosis-Related LncRNA Signature for Predicting Prognosis, Immune Features and Drug Sensitivity in Ovarian Cancer
Liu PW, Liu ZY, Deng SJ, Zhang X, Wang ZB, Wu NY, Liu CS, Hu MH, Wang J, Li H
OncoTargets and Therapy 2025, 18:585-601
Published Date: 23 April 2025
Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date
Gogtay M, Aimalla N, Thirugnanasambandam RP, Ganti AK
OncoTargets and Therapy 2025, 18:575-584
Published Date: 23 April 2025
Based on Soluble Immune Checkpoints Constructing a Random Survival Forest Model to Predict the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Cai X, Yu L, Liu X, Yan H, Xie Y, Pu Q, Shang Z, Wu Y, Jiang T, Yang Z
OncoTargets and Therapy 2025, 18:559-573
Published Date: 19 April 2025
Research Progress of GPR137 in Malignant Tumors: A Review
Li Y, Yi Z, Li X, Wang R, Zhao M, Mi L, Zhang W, Guo R, Yan S, Song J
OncoTargets and Therapy 2025, 18:545-558
Published Date: 15 April 2025
Combination of Aumolertinib, Dabrafenib, and Trametinib for a Patient with Advanced Lung Adenocarcinoma with an Osimertinib-Induced BRAF V600E Mutation: A Case Report
Wang D, Ye W, Yin Z, Xu N, Ma J
OncoTargets and Therapy 2025, 18:539-544
Published Date: 13 April 2025
Integrated Genomic Analysis of Lung Squamous Cell Carcinoma Subtypes Characterized by Immunogenic Cell Death-Relevant Gene Signature
Wang Y, Wang S, Ding R, Zhang Z, Kong J, Xie T, Xu B, Fu L, Zhang E
OncoTargets and Therapy 2025, 18:521-537
Published Date: 11 April 2025
Management of Regorafenib-Induced Hand-Foot Skin Reaction with Topical Chinese Medicine and Urea Ointment: A Case Report and Literature Review
Liu ZN, Shen YL, Dong HJ, Tan KX, Li J, Peng YM, Cui HJ
OncoTargets and Therapy 2025, 18:509-519
Published Date: 9 April 2025
Neoadjuvant Targeted Therapy with Dacomitinib in a Stage IIIA Non-Small-Cell Lung Cancer Patient Harboring EGFR G719X: A Case Report
Li D, Liu X, Liu Y, Zhu Y, Yang D, Song J, Dai Z
OncoTargets and Therapy 2025, 18:503-507
Published Date: 5 April 2025
Anti-Tumor Effects of Gilteritinib on FLT3 Mutations: Insights into Resistance Mechanisms in Ba/F3 Cell Models
Nakazawa T, Tsuzuki H, Kawase T, Mori M, Yoshida T
OncoTargets and Therapy 2025, 18:489-501
Published Date: 3 April 2025
Waldenström Macroglobulinemia and Chronic Myelomonocytic Leukemia: Case Report and Literature Review
Pan Y, Wang Y, Wang Q
OncoTargets and Therapy 2025, 18:481-487
Published Date: 3 April 2025
Exploring Protein Expression Profiles in Lung Cancer Insufficient Microwave Ablation: Implications for Recurrence
Yan P, Yuan R, Li Z, Sun M
OncoTargets and Therapy 2025, 18:467-479
Published Date: 3 April 2025
Integrating Bulk and Single-Cell RNA Sequencing Data Reveals the Prognostic Significance of HOXC9-Related Immune Gene Signatures in Hepatocellular Carcinoma
Zhang Y, Sun H, Bo W, An Z, Li J
OncoTargets and Therapy 2025, 18:453-465
Published Date: 29 March 2025
Coumarins from Citrus aurantiifolia (Christm.) Swingle Peel with Potential Cytotoxic Activity Against MCF-7 Breast Cancer Cell Line: In Vitro and In Silico Studies
Julaeha E, Mulyawan FE, Anwar FM, Akili AWR, Permadi N, Darwati, Kurnia D, Herlina T
OncoTargets and Therapy 2025, 18:441-452
Published Date: 30 March 2025
Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation Landscape
Wang Y, Zhang L, Du Y, Yan T, Yang F, Yang Y, Liu B, Xie L
OncoTargets and Therapy 2025, 18:429-439
Published Date: 29 March 2025
PCSK9 Manipulates Lipid Metabolism and the Immune Microenvironment in Cancer
Cui C, Yan A, Huang S, Chen Y, Zhao J, Li C, Wang X, Yang J
OncoTargets and Therapy 2025, 18:411-427
Published Date: 27 March 2025
Prognostic and Immunological Significance of NMNAT1 in Colorectal and Pan-Cancer Contexts
Wen L, Wang P, Zhang G, Ma Y, Li J, Chen D, Liu L, Hu H, Huang C, Yao X
OncoTargets and Therapy 2025, 18:389-410
Published Date: 25 March 2025
Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study
Iso H, Yomota M, Shirakura Y, Yoshinaga T, Kawai S, Narita K, Seike M, Hosomi Y
OncoTargets and Therapy 2025, 18:379-387
Published Date: 19 March 2025
Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
Farooq A, Amin A, Bashir S, Fatima M, Hassan M, Sheikh AZ, Tahseen M, Sheikh UN, Asghar K
OncoTargets and Therapy 2025, 18:367-377
Published Date: 17 March 2025
CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP
Cerón Maldonado R, Martínez Tovar A, Ramos Peñafiel CO, De la Cruz Rosas A, García Laguna AI, Mendoza Salas I, Martínez Murillo C, Barranco Lampón GI, Montaño Figueroa EH, Jiménez-Morales S, Olarte Carrillo I
OncoTargets and Therapy 2025, 18:355-366
Published Date: 14 March 2025
Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and Target in a Variety of Tumors, Especially in Cervical Cancer
Ning L, Li X, Xu Y, Si Y, Zhao H, Ren Q
OncoTargets and Therapy 2025, 18:335-353
Published Date: 14 March 2025
Comprehensive Treatment of Anaplastic Thyroid Cancer: A Case Report
Liu J, Chu J
OncoTargets and Therapy 2025, 18:325-333
Published Date: 10 March 2025
Patient-Derived Organoids for Guiding Neoadjuvant Chemotherapy in Bilateral Primary Breast Cancer: A Case Report
Cao M, Wang R, Cheng X, Yu H, Tong Q, Yao Y
OncoTargets and Therapy 2025, 18:319-324
Published Date: 6 March 2025
The Landscape of PARP Inhibitors in Solid Cancers
Muzzana M, Broggini M, Damia G
OncoTargets and Therapy 2025, 18:297-317
Published Date: 2 March 2025
Efficacy and Safety of Combined PD-1 Inhibitor With Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis
Chen K, Huang X, Chen J, Zhang S
OncoTargets and Therapy 2025, 18:283-296
Published Date: 26 February 2025
Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma
Alahmadi RM, Awadalla M, Marraiki N, Alswayyed M, Alshehri HA, Alsahli A, Khoja HA, Khojah OT, Alahmadi RM, Farid N, Alosaimi B
OncoTargets and Therapy 2025, 18:263-281
Published Date: 20 February 2025
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Sheikh KA, Amjad M, Irfan MT, Anjum S, Majeed T, Riaz MU, Jassim AY, Sharif EAM, Ibrahim WN
OncoTargets and Therapy 2025, 18:233-262
Published Date: 18 February 2025
Comprehensive Analysis Identifies Hsa_circ_0058191 as a Potential Drug Resistance Target in Multiple Myeloma
Yang H, Zhu J, Wang X
OncoTargets and Therapy 2025, 18:225-231
Published Date: 12 February 2025
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
Wang B, Shen C, Liu D, Dong Z, Lin X, Liao H
OncoTargets and Therapy 2025, 18:211-224
Published Date: 11 February 2025
Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer
Cong B, Cao X, Jiang WG, Ye L
OncoTargets and Therapy 2025, 18:199-209
Published Date: 4 February 2025
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells
Wu D, Zhang Y, Zhang L, Xia W, Cai B, Dong F, Wu K, Cheng L, Shao M, Ma H, Hu Z, Lu H
OncoTargets and Therapy 2025, 18:179-197
Published Date: 4 February 2025
Crosstalk of SPINK4 Expression With Patient Mortality, Immunotherapy and Metastasis in Pan-Cancer Based on Integrated Multi-Omics Analyses
Cao X, Luo N, Liu X, Guo K, Deng M, Lv C
OncoTargets and Therapy 2025, 18:161-177
Published Date: 4 February 2025
Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1
Leguay K, Kent OA
OncoTargets and Therapy 2025, 18:147-159
Published Date: 25 January 2025
Exploration and Identification of Vitamin D and Related Genes as Potential Biomarkers for Colorectal Tumors
Wang L, Xu R, Wang M, Wang M, Su S, Nian Y, Chen X
OncoTargets and Therapy 2025, 18:129-145
Published Date: 22 January 2025
Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker, with an Emphasis on Cervical Cancer
Liu J, Zhang Q, He L, Hu H, Wang Y, Xie P
OncoTargets and Therapy 2025, 18:107-127
Published Date: 22 January 2025
Research Progress of NK Cells in Glioblastoma Treatment
Wu H, Liu Q, Wang F, Gao W, Zhou F, Zhao H
OncoTargets and Therapy 2025, 18:87-106
Published Date: 18 January 2025
Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course Radiotherapy
Lin YH, Hsu HC, Huang EY
OncoTargets and Therapy 2025, 18:73-86
Published Date: 16 January 2025
Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer
Ying H, Kong W, Xu X
OncoTargets and Therapy 2025, 18:49-71
Published Date: 16 January 2025
Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer
Zhang X, Zhang X, Yin H, Li Q, Fan B, Jiang B, Xie A, Guo D, Hao H, Zhang B
OncoTargets and Therapy 2025, 18:35-47
Published Date: 16 January 2025
A Rare Case of Post-Transplant Lymphoproliferative Disorder Presenting as Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review
Chen Y, Chen Y, He Y, Mu Q, Ouyang G
OncoTargets and Therapy 2025, 18:27-33
Published Date: 14 January 2025
High Intelectin‐1 Expression Associated with Aggressive Tumor Behavior and Worse Survival in Rectal Cancer
Chou CL, Lin CW, Li WS, Chen TJ, Lee SW, Tian YF, Kuo YH, Tsai HH, Wu LC, Yeh CF, Shiue YL, Lai HY, Yang CC
OncoTargets and Therapy 2025, 18:15-26
Published Date: 13 January 2025
Recent Advances in Understanding the Clinical Responses of Brentuximab Vedotin in Lymphoma and the Correlation with CD30 Expression
Chen W, Zhang Z
OncoTargets and Therapy 2025, 18:1-14
Published Date: 6 January 2025